Fiji vs Sudan: Access to anti-retroviral drugs, female
Fiji
18.0%
in 2024
Sudan
19.0%
in 2024
Fiji rank
141st
Sudan rank
140th
Access to anti-retroviral drugs, female over time
- Fiji
- Sudan
How they compare
Sudan currently reports 19.0% against 18.0% in Fiji, a difference of 1.0%.
That makes Sudan's figure about 1.1 times Fiji's.
The two have swapped places 2 times across 22 shared years of data; in 2000 it was Sudan ahead.
Fiji ranks 141st and Sudan ranks 140th of 141 countries.
Across the 3 decades both report, Fiji averaged higher in 2 and Sudan in 1.
Head to head by decade
| Decade | Fiji | Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 36.3% | 1.6% | 34.7% | Fiji |
| 2010s | 45.9% | 14.5% | 31.4% | Fiji |
| 2020s | 17.8% | 23.4% | 5.6% | Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Fiji or Sudan?
- Sudan, at 19.0% against 18.0% in Fiji as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Fiji and Sudan?
- 1.0%, with Sudan ahead.
- How many years of comparable data are there for Fiji and Sudan?
- 22 years are reported by both, from 2000 to 2024.
- How do Fiji and Sudan rank globally for access to anti-retroviral drugs, female?
- Fiji ranks 141st and Sudan ranks 140th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.